NuVasive (NUVA) Misses Q3 EPS by 23c; Lowers Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
NuVasive (NUVA) PT Lowered to $75 at Truist Securities
November 10, 2021 6:48 AM ESTTruist Securities analyst Samuel Brodovsky lowered the price target on NuVasive (NASDAQ: NUVA) to $75.00 (from $80.00) while maintaining a Buy rating.
The analyst commented, "NUVA reported 3Q results with sales of $271M down ~8% sequentially, while adj. EPS came in at $0.32. Updated... More
NuVasive (NUVA) PT Lowered to $64 at Needham & Company
November 10, 2021 6:25 AM ESTNeedham & Company analyst Mike Matson lowered the price target on NuVasive (NASDAQ: NUVA) to $64.00 (from $73.00) while maintaining a Buy rating.
The analyst commented, "NUVA's 3Q21 revenue was in line with its preannouncement while its EPS missed consensus. Management lowered 2021 revenue guidance... More

